MiR-200c has been reported to inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1; meanwhile, miR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway36,37. Here, VEGFA is linked to non-small cell lung carcinoma.